RecruitingACTRN12620000703909
CADET candesartan trial for depression in bipolarity: a double-blind, randomised, placebo-controlled trial
Interventional studyAges 18+Australia
Understand this study
Who could participate?
The study seeks adults with bipolarity type I or II who are experiencing a moderate to severe depressive episode.
What does the protocol involve?
The protocol compares daily candesartan with placebo (an inactive comparison treatment) for 16 weeks alongside existing care.
- Listed locations
- Geelong and 4 more locationsSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateSeptember 1, 2021
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 240
- Sponsor
- Deakin University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Australia
- Age range
- From 18 Years to No limit
- Official registry ID
- ACTRN12620000703909
- Official title
Show the full official title
The Candesartan Adjunctive Bipolar Depression Trial - CADET: A double-blind, randomised, placebo-controlled trial to evaluate the effect of Candesartan on mood in patients with bipolar depression
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Geelong · Richmond · Melbourne
2 more locations
- Box Hill
- Toowong
Next step · Check the registry for the research team’s contact details.
HopeStage summarises and translates information from the ANZCTR registry.
Updated by the registry
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Deakin University, a university.
Does this study involve medication?
Yes. The study involves medication, including Candesartan and Placebo.
Who could participate?
The study seeks adults with bipolarity type I or II who are experiencing a moderate to severe depressive episode.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to explore more studies?
Explore studiesRelated studies
MELODY Trial: A 12-week randomised controlled trial of adjunctive melatonin or digital cognitive behavioural therapy for insomnia, or placebo to improve depressive symptoms in young adults with mood disorders
The Kite Trial: Examining the Effectiveness of Ketamine for Adults with Depression in bipolarity
